Network analysis of matched sets
For all three outcomes, direct and indirect comparisons between Group A and Group B subjects were consistent, so it was justified to combine then (Figure 4): there was no indication that outpatients prescribed fluvoxmine around the time of COVID-19 diagnosis (Group A) were at a reduced risk of any of the outcomes as compared to their peers burdened with similar psychiatric difficulties but not prescribed fluvoxamine over the critical period of time (Group B) (Figure 4). Closely similar patterns were seen for the Group A vs. Group C comparisons (not shown).